ClinicalTrials.Veeva

Menu

Incidence of Trauma Induced Coagulopathy in Patients With Prehospital Administration of Fibrinogen (TICAF)

M

Masaryk University

Status

Completed

Conditions

Coagulopathy
Hemorrhage
Trauma

Study type

Observational

Funder types

Other

Identifiers

NCT03572309
CT0022018

Details and patient eligibility

About

The purpose of the study is to find out the incidence of trauma induced coagulopathy in patients with severe trauma who received fibrinogen prior admission to emergency department during prehospital care.

Full description

The study will commence following the Approval by The Ethics Research Committee. All patients admitted to emergency department during the study will be enrolled after fulfilling the inclusion criteria and in the absence of any exclusion criteria. Informed consent will be requested. After admission to emergency department the blood samples will be taken and blood tests and viscoelastic tests will be performed. All data and results will be entered in the study form. Statistical analysis will be performed and incidence of trauma induced coagulopathy estimated. In addition, 28-day mortality and the incidence of thromboembolic complications will be monitored.

Enrollment

28 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • multiple trauma, injury severity score (ISS) ≥16
  • administration of fibrinogen in prehospital care
  • age 18-80 years

Exclusion criteria

  • ISS 75
  • pregnancy
  • therapeutic anticoagulation
  • therapeutic antiaggregation

Trial contacts and locations

1

Loading...

Central trial contact

Ondrej Hrdy, MD; Kamil Vrbica, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems